Low-GDP fluid (Gambrosol trio(R)) attenuates decline of residual renal function in PD patients: a prospective randomized study

Abstract

Our prospective study demonstrates for the first time a significant benefit concerning preservation of RRF and urine volume of using a PD fluid with low GDP levels. These findings suggest that GDPs might affect patient outcome related to RRF.